Recent Blog Posts
View Post: What is the Role of Drug Therapy in Treating Obesity?
Clinical ...
19 Nov 2009 by Clinical Correlations ...
View Blog: http://www.clinicalcorrelations.org/
View Post: CIENCIASMEDICASNEWS: Early Communication about an Ongoing Safety ...
21 Nov 2009 by salud equitativa
Meridia (sibutramine 5mg, 10mg, 15mg) was approved by FDA in 1997 for the management of obesity, including weight loss and maintenance of weight loss, in conjunction with a reduced calorie diet. Meridia is only recommended for obese ...
View Blog: CIENCIASMEDICASNEWS - http://elbiruniblogspotcom.blogspot.com/
View Post: OSI Pharmaceuticals Provides Update On Diabetes And Obesity ...
18 Nov 2009 by admin
The data from this study is supportive of progression of PSN602 into a 28-day dosing clinical study, at a top dose of 20mg daily, with weight loss as the primary endpoint and sibutramine as a comparator, and will be presented at a ...
View Blog: Discuss Pharmacy - http://discusspharmacy.com/
View Post: Reductil (sibutramine) â?? Slimming and Diet Pill
Slim Pills
13 Nov 2009 by admin ...
View Blog: http://slimpills.net/
View Post: Treatment For Obesity,Weight Loss Products Sibutramine
2 Oct 2009 by jeriko
Sibutramine trade name Meridia in the US and Canada, Ectiva in South Africa, Reductil in Europe and most other countries, usually as sibutramine hydrochloride monohydrate, is an orally administered agent for the treatment of obesity, ...
View Blog: 11th Hour Action blogs - http://11thhouraction.com/blog
View Post: OhioLINK EJC - Effects of liraglutide in the treatment of obesity ...
9 Nov 2009
“Drug treatments for obesity: orlistat, sibutramine, and rimonabant.” Lancet . v. 369 p. 71–77. 2007. [Find It]; Zelissen, PMJ; Stenlof, K; Lean, MEJ. “Effect of three treatment schedules of recombinant methionyl human leptin on body ...
View Blog: The Lancet (OhioLINK EJC) - http://rave.ohiolink.edu/ejournals/issn/01406736
View Post: Donna H. Ryan, M.D., Elected President of The Obesity Society for ...
13 Nov 2009
Dr. Ryan's interest in obesity research was mentored by George Bray, beginning with a 1992 dose-ranging study of sibutramine. She has been an Investigator on DPP (Diabetes Prevention Program), Co-PI of POUNDS Lost (macronutrient ...
View Blog: Latest Medical News from Bio-Medicine.Org - http://www.bio-medicine.org/medicine-news-1/Loma-Lind...
View Post: Booming Global Obesity Drug Market
Health Habits
7 Mar 2009 by DR ...
View Blog: http://healthhabits.wordpress.com/
View Post: Variegate porphyria in a 46-year-old patient taking sibutramine ...
20 Oct 2009 by Obesity Reviews
We describe the case of a 46-year-old female patient presenting with a first episode of symptomatic porphyria after 10 d of sibutramine treatment for weight loss. Genetic analysis showed a heterozygous R168H hot spot mutation in the ...
View Blog: ExcitingAds! Obesity - http://www.medworm.com/rss/search.php?qu=obesity+obese+overweight&t=Obesit...

Not Signed In -

